-
Mashup Score: 13
Nature – The molecular characteristics of myocarditis associated with immune checkpoint inhibitors are described and potential biomarkers of onset and severity are identified.
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 86
Nature – The molecular characteristics of myocarditis associated with immune checkpoint inhibitors are described and potential biomarkers of onset and severity are identified.
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet-
In @Nature, a collaboration with @kreynoldsMD, @villanilab, @sm_blum, @DZlotoff from @MGHCancerCenter, @MGHMedicine and others. Immune response in checkpoint myocarditis. Sincere thanks to the patients and families. @mghcvrc @ICOSociety. @MGHHeartHealth https://t.co/x12irrcWeP
-
-
Mashup Score: 86
Nature – The molecular characteristics of myocarditis associated with immune checkpoint inhibitors are described and potential biomarkers of onset and severity are identified.
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet-
In @Nature, a collaboration with @kreynoldsMD, @villanilab, @sm_blum, @DZlotoff from @MGHCancerCenter, @MGHMedicine and others. Immune response in checkpoint myocarditis. Sincere thanks to the patients and families. @mghcvrc @ICOSociety. @MGHHeartHealth https://t.co/x12irrcWeP
-
-
Mashup Score: 3Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer - PubMed - 2 year(s) ago
Low LV mass is associated with poor functional status and increased all-cause mortality in cancer. These findings provide clinical evidence of cardiac wasting-associated cardiomyopathy in cancer.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Evidence of a cardiac wasting-associated cardiomyopathy in cancer where low LV mass was associated with poor functional status and increased all-cause mortality. https://t.co/sx5hsEobUi https://t.co/RPxxp4WYpO
-
-
Mashup Score: 2Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds - 2 year(s) ago
Premature heart disease and other chronic conditions have emerged as leading causes of morbidity and mortality.
Categories: Cardiologists, Latest HeadlinesTweet-
Practice changing study, funded by @NIH and co-led by colleagues @CIRC_MGH and @MGHMedicine, persons with HIV on pitavastatin, who were considered to be at a low risk for an event, had a 35% lower rate of major cardiovascular events compared to placebo: https://t.co/k02tXAXth2
-
-
Mashup Score: 4Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients - PubMed - 2 year(s) ago
Chimeric antigen receptor T-cell therapy recipients who experience SCE have higher overall mortality and NRM and higher peak levels of IL-6, CRP, ferritin, and troponin.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Led by @SaadMahmoodMD with many colleagues in #cardioonc and oncology, a multicenter study in @ESC_Journals showing that cardiac events after CAR-T are important and are associated with higher overall mortality and non-relapse mortality. https://t.co/sca1jocYWT. @ICOSociety
-
-
Mashup Score: 2Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract As the clinical applications of immune checkpoint inhibitors (ICIs) expand, our knowledge of the potential adverse effects of these drugs continues to broaden. Emerging evidence supports t…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
From @jaccjournals, over 30% of cancer patients are eligible for an ICI. A review on the potential for ICI related atherosclerosis - JACC: CardioOncology led by the amazing @GiselleSA_MDPhD from @MGHHeartHealth and @MGHCVFellows https://t.co/EuuxbMZQkU
-
-
Mashup Score: 1Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer - 2 year(s) ago
Objectives Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce heart failure (HF) in at-risk patients and may possess antitumour effects. We examined the effect of SGLT2i on HF and mortality among patients with cancer and diabetes. Methods This was a retrospective propensity score-matched cohort study involving adult patients with type 2 diabetes mellitus diagnosed with cancer between…
Source: HeartCategories: Cardiologists, Latest HeadlinesTweet-
Sodium-glucose cotransporter-2 inhibitors and heart failure and mortality in patients with cancer https://t.co/j9R3QdMo5G In a large mostly non-anthracycline cancer population, SGLT2i use was associated with lower incident HF and prolonged overall survival
-
-
Mashup Score: 3The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer - PubMed - 2 year(s) ago
This study aims to evaluate the efficacy of the Pooled Cohort Equation (PCE), U.S. Preventative Services Task Force (USPSTF), and Framingham Risk Score (FRS) models in predicting ASCVD events among patients receiving radiation therapy (RT) for head and neck cancer (HNCA). From a large cohort of HNCA …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Led by Dr. Raza Alvi with a team including @CIRC_MGH, and @md_addison, @mghcvrc, @MGHCVFellows - @GiselleSA_MDPhD and Oncology colleagues from @MGHCancerCenter. Standard Prediction Models underestimate CV events after RT. A statin for all after RT? https://t.co/FqfeHDLDpO
-
-
Mashup Score: 0Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors - 2 year(s) ago
Immune checkpoint inhibitors (ICIs) improve clinical outcomes in various cancers, but sometimes induce autoimmune adverse effects, including myocardit…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Prospective screening for myocarditis in 126 patients treated with an immune checkpoint inhibitor. With serial evaluation, an elevated troponin I was observed in 14.3 % but most did not have myocarditis. https://t.co/MhMiSNfkXq
-
In @Nature, a collaboration with @kreynoldsMD, @villanilab, @sm_blum, @DZlotoff from @MGHCancerCenter, @MGHMedicine and others. Immune response in checkpoint myocarditis. Sincere thanks to the patients and families. @mghcvrc @ICOSociety. @MGHHeartHealth https://t.co/x12irrcWeP